Merit Medical Sees FY24 Adj. EPS $3.28-$3.35 Vs $3.32 Est.; Net Sales $1.312B-$1.325B Vs $1.32B Est.
Portfolio Pulse from Benzinga Newsdesk
Merit Medical forecasts its FY24 adjusted EPS to be between $3.28 and $3.35, compared to the estimated $3.32. The company also projects net sales to range from $1.312 billion to $1.325 billion, closely aligning with the estimated $1.32 billion.
April 30, 2024 | 8:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Merit Medical forecasts FY24 adjusted EPS and net sales closely aligning with analyst estimates, indicating stable financial expectations.
Merit Medical's forecast for FY24 adjusted EPS and net sales closely matches analyst estimates, suggesting the company's performance is in line with market expectations. This alignment typically reassures investors about the company's financial health and strategic direction, potentially leading to a positive short-term impact on the stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100